Freudiger Photonics

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.

The US DOT Volpe Center in Cambridge, MA is a research and development facility that focuses on transportation and infrastructure innovation. Through collaboration with government agencies and industry partners, the center conducts studies and provides technical expertise to address complex transportation challenges. With a team of experts in various fields, the US DOT Volpe Center conducts research to improve safety, efficiency, and sustainability in transportation systems. Their work plays a crucial role in shaping policies and technologies that impact the future of transportation both nationally and globally. Generated from their business information

Izentis LLC is a technology research and development company based in Cambridge, MA, specializing in microfabrication services and custom engineering consulting. With a focus on high precision engineering and aerospace technology, Izentis LLC offers a range of products and services including diffraction gratings, custom microfabrication equipment, and consulting for static rocket testing and beamed energy propulsion vehicles.Generated from the website